P

R

PAREO , Rosaria M.

Last name: PAREO

First name: Rosaria M.

2018 (v1)

Publication

Metadata-only

Serenoa repens + selenium + lycopene vs tadalafil 5 mg for the treatment of lower urinary tract symptoms secondary to benign prostatic obstruction: a Phase IV, non-inferiority, open-label, clinical study (SPRITE study)

Morgia, Giuseppe Vespasiani, Giuseppe Pareo, Rosaria M.

Objective: To compare in a randomised, open-label, non-inferiority clinical study, the efficacy and tolerability of Serenoa repens (SeR) + selenium (Se) + lycopene (Ly) (SeR-Se-Ly) therapy vs tadalafil 5 mg in men with lower urinary tract symptoms (LUTS). Patients and methods: From May 2015 to January 2017, 427 patients were enrolled in 21...

Uploaded on: April 14, 2023